AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bortecad 2.5 Injection

Prescription Icon
Prescription Required

Marketer

Cadila Pharmaceuticals Ltd

Salt Composition

Bortezomib (2.5mg)

Overview Bortecad 2.5 Injection

Myeloma and mantle cell lymphoma are treated with the injectable medication, Bortecad 2.5. Its mechanism involves inhibiting or decelerating cancerous cell proliferation. Administration is strictly by injection from a qualified healthcare provider. Dosage frequency and amount are determined by your physician based on your condition and may be adjusted. Adhere precisely to your doctor's prescribed regimen; improper usage or overdose can lead to severe adverse effects. Therapeutic benefits might not be apparent for weeks or months; discontinue only upon your doctor's instruction. Common side effects include fatigue, nausea, vomiting, and appetite suppression. Increased daily fluid intake may be recommended. Operation of machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can reduce blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, as well as heart, liver function, and uric acid, are essential. Prior to commencing treatment, individuals with liver, kidney, heart disease, or bleeding disorders must consult their physician. Report any cognitive symptoms such as memory impairment or difficulty concentrating. Inform your healthcare team of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout the treatment period.

Uses of Bortecad 2.5 Injection

Myeloma and mantle cell lymphoma

Major Benefits of Bortecad 2.5 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Bortecad 2.5 Injection:

  • Low blood platelets
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Psychiatric disturbances
  • Nausea
  • Vomiting
  • Loss of appetite
  • Fever
  • Anemia (low number of red blood cells)
  • Diarrhea
  • Decreased appetite
  • Decreased white blood cell count (neutrophils)
  • Constipation

How to use Bortecad 2.5 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Bortecad 2.5 Injection works:

Bortecad 2.5 Injection is an anticancer drug that inhibits the degradation of cellular proteins. This accumulation of proteins within cancer cells ultimately triggers their demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Bortecad 2.5 Injection and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Bortecad 2.5 Injection during pregnancy is contraindicated due to confirmed risks to fetal development. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Bortecad 2.5 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.

DrivingDrivingUNSAFE

Administering Bortecad 2.5 Injection may induce adverse reactions that impair driving capabilities. These potential side effects include fatigue, vertigo, syncope, or visual disturbances, all of which could negatively impact driving performance.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Bortecad 2.5 Injection cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Bortecad 2.5 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Bortecad 2.5 Injection :

Omit a Bortecad 2.5 Injection dose? Seek your physician's advice.

Facts to Know About Bortecad 2.5 Injection

LabelValue
Chemical Category Phenylalanine-based Compounds
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Bortecad 2.5 Injection

Seek immediate medical attention for muscle cramps, weakness, confusion, vision problems (including blindness), seizures, headaches, shortness of breath, swollen feet, irregular heartbeat, high blood pressure, fatigue, fainting, or chest tightness and breathing difficulties.
Continue this medication precisely as prescribed until your doctor instructs otherwise. Regular scans will monitor the tumor's response to treatment, with scheduling determined by your physician.
Bortecad 2.5 Injection reduces white blood cells and platelets, increasing your infection and bleeding risk. Avoid contact with sick individuals. Report any fever, chills, cough, or suspected infection to your doctor immediately. Use caution with sharp objects and a soft-bristled toothbrush to minimize bleeding.
This medication is contraindicated during pregnancy due to the risk of harm to the fetus. Effective contraception is required throughout treatment and for three months following your final Bortecad 2.5 Injection dose.
This medication carries a risk of potentially fatal lung problems. Seek immediate medical attention if you experience severe shortness of breath, confusion, a dry cough, dizziness, or excessive fatigue.
This medication may cause hair brittleness, breakage, patchy loss, or thinning. These side effects usually disappear after treatment ends. Handle your hair gently during washing and brushing to minimize shedding.
This medication may cause tingling, numbness, pain, or burning in your arms or legs. Reduced sensation can impair balance and coordination, increasing your fall risk. Report these symptoms to your doctor; your dosage or treatment schedule may need adjustment.
Soothe rashes and dry, itchy skin with a moisturizer. Protect your skin from sun exposure by wearing protective clothing and using sunscreen with SPF 15 or higher. Refrain from swimming while experiencing a rash, as chlorine can aggravate it. Avoid hot showers and wear loose-fitting cotton clothing. Skin improvement is expected after treatment ends.
Ease constipation by eating plenty of fiber-rich fruits and vegetables, drinking eight to ten glasses of water daily, and staying active. A doctor-prescribed stool softener, taken once or twice a day, can also help prevent constipation. Seek medical advice if you haven't had a bowel movement in two to three days.
This medication may cause nausea and fatigue. To ease nausea, try eating smaller, more frequent meals and avoid salty, spicy, fatty, or fried foods. Combat fatigue with adequate rest and light daily exercise.
Changes in taste are common during cancer treatment; you might notice a metallic taste, a loss of taste, or a sudden dislike for previously enjoyed foods and drinks. To help counter this, try rinsing your mouth with a salt and baking soda solution before meals. Adding extra flavorings or seasonings to your food can also be beneficial.
Bortecad 2.5 Injection
3,434